Gastroenterology Practice Questions

Q: A 45-year-old woman presents with jaundice, pruritus, and periocular and intradigital xanthomas. Her laboratory results indicate a significantly increased alkaline phosphatase and a positive test for antimitochondrial antibodies. What is the most likely cause of her symptoms?

Primary biliary cirrhosis. **Explanation:** The clinical presentation is a classic case of **Primary Biliary Cholangitis (PBC)**, formerly known as Primary Biliary Cirrhosis. **1. Why the Correct Answer is Right:** PBC is a chronic autoimmune cholestatic liver disease characterized by the destruction of small intrahepatic bile ducts [1]. The patient exhibits the classic triad: * **Symptoms:** Jaundice and intense pruritus (often the earliest symptom) [1]. * **Physical Signs:** Xanthomas (periocular xanthelasma and intradigital) occur due to chronic cholestasis leading to hyperlipidemia [1]. * **Biochemical/Serological Markers:** A disproportionate rise in **Alkaline Phosphatase (ALP)** and the presence of **Antimitochondrial Antibodies (AMA)**, which are highly specific (>95%) for PBC [3]. **2. Why the Other Options are Wrong:** * **Leptospirosis:** Typically presents acutely with high fever, conjunctival suffusion, and muscle pain (Weil’s disease). It does not cause chronic xanthomas or AMA positivity. * **Macronodular Cirrhosis:** This is a morphological description of cirrhosis (often post-viral). While it causes jaundice, it lacks the specific cholestatic features and AMA markers seen here. * **Primary Sclerosing Cholangitis (PSC):** While it causes cholestasis, it primarily affects the large extra- and intrahepatic ducts (showing a "beaded appearance" on MRCP). It is strongly associated with **Ulcerative Colitis** and **p-ANCA**, not AMA [3]. **3. NEET-PG High-Yield Pearls:** * **Mnemonic for PBC:** The "4 Ms": **M**iddle-aged women, **M**arkedly raised ALP, **M**itochondrial antibodies (AMA), and **M**anagement with Ursodeoxycholic acid (UDCA) [3]. * **Associated Conditions:** Sjögren’s syndrome, Hashimoto’s thyroiditis, and Celiac disease [2]. * **Gold Standard Diagnosis:** Liver biopsy (shows "florid duct lesions"). * **Treatment:** UDCA slows progression; Liver transplant is the definitive treatment for end-stage disease.

Q: Which of the following statements about Hepatitis C is true?

It is the most common indication for liver transplant.. **Explanation:** **Hepatitis C Virus (HCV)** is a major cause of chronic liver disease worldwide. The correct answer is **Option B** because chronic HCV infection frequently leads to cirrhosis and hepatocellular carcinoma (HCC). Due to the high burden of end-stage liver disease (ESLD) resulting from decades of chronic infection, it remains the leading indication for liver transplantation globally, particularly in the Western world. **Analysis of Incorrect Options:** * **Option A:** HCV is a single-stranded, enveloped **RNA virus** belonging to the *Flaviviridae* family. Hepatitis B is the only DNA virus among the common hepatotropic viruses (A, B, C, D, E). * **Option C:** HCV is a potent **oncogenic virus**. Chronic infection is a major risk factor for **Hepatocellular Carcinoma (HCC)**, often occurring after the development of cirrhosis. * **Option D:** **Coinfection** with Hepatitis B (HBV) is possible and often results in more severe liver disease, faster progression to cirrhosis, and a higher risk of HCC compared to monoinfection. **High-Yield Clinical Pearls for NEET-PG:** * **Transmission:** Primarily parenteral (IV drug use is the most common route). Sexual and vertical transmission are less efficient than in HBV. * **Chronicity:** HCV has the highest rate of chronicity (~55–85%) among hepatitis viruses. * **Extrahepatic Manifestations:** Mixed cryoglobulinemia, Membranoproliferative glomerulonephritis (MPGN), and Porphyria cutanea tarda. * **Treatment:** The current standard of care involves **Direct-Acting Antivirals (DAAs)** like Sofosbuvir, which offer a cure rate (SVR) of >95%. * **Screening:** Anti-HCV antibody is the screening test [1]; HCV-RNA (PCR) is the gold standard for confirming active infection [1].

Q: A patient complains of intermittent dysphagia, which is equal for both solids and liquids. What is the most common cause?

Diffuse Esophageal Spasm (DES). The clinical hallmark of **motility disorders** of the esophagus is dysphagia that occurs for **both solids and liquids** simultaneously from the onset [1]. **Why Diffuse Esophageal Spasm (DES) is correct:** DES is characterized by uncoordinated, non-peristaltic contractions of the esophageal body. The classic presentation is **intermittent** dysphagia for both solids and liquids, often triggered by very hot or cold beverages. It is frequently associated with retrosternal chest pain that mimics angina [1]. On a barium swallow, it classically shows a **"Corkscrew esophagus"** or "Rosary bead esophagus." **Analysis of Incorrect Options:** * **Achalasia Cardia:** While it also causes dysphagia for both solids and liquids, the dysphagia is typically **progressive** rather than intermittent [1]. It is characterized by a failure of the Lower Esophageal Sphincter (LES) to relax and a lack of peristalsis. * **Esophageal Stricture:** This is a mechanical/structural obstruction. These conditions typically present with dysphagia for **solids first**, which only progresses to liquids as the lumen narrows further [1]. * **Carcinoma:** Similar to strictures, malignancy presents as **progressive** dysphagia starting with solids [1]. It is usually accompanied by "red flag" symptoms like significant weight loss and anemia. **NEET-PG High-Yield Pearls:** * **Gold Standard Diagnosis:** Manometry is the investigation of choice for DES (shows high-amplitude, simultaneous contractions in >20% of swallows) [1]. * **Nutcracker Esophagus:** A related motility disorder where contractions are coordinated (peristaltic) but have very high pressure (>180 mmHg) [1]. * **Treatment of DES:** Nitrates and Calcium Channel Blockers (CCBs) are first-line to relax smooth muscle; Myotomy is reserved for refractory cases [1].

Q: A 50-year-old woman presents with duodenal ulcer disease and high basal acid secretory outputs. Secretin stimulated serum gastrin levels are in excess of 1000pg/mL. She has a long history of ulcer disease that has not responded to intense medical therapy. What is the most likely diagnosis?

Zollinger-Ellison syndrome. ### Explanation **Correct Answer: D. Zollinger-Ellison syndrome (ZES)** The clinical presentation is classic for **Zollinger-Ellison Syndrome**, caused by a gastrin-secreting neuroendocrine tumor (gastrinoma) [1]. * **Hypergastrinemia:** A serum gastrin level >1000 pg/mL in the presence of high gastric acid (Basal Acid Output >15 mEq/hr) is virtually diagnostic [1][2]. * **Secretin Stimulation Test:** This is the most sensitive provocative test. In ZES, secretin paradoxically **increases** gastrin levels (usually by >200 pg/mL). In normal individuals, secretin inhibits gastrin. * **Refractory Ulcers:** Ulcers that are multiple, distal to the duodenal bulb, or non-responsive to standard PPI therapy strongly suggest ZES. **Why Incorrect Options are Wrong:** * **A. Hyperparathyroidism:** While associated with ZES in **MEN1 syndrome**, hyperparathyroidism itself causes hypercalcemia, which can mildly increase gastrin, but it does not produce the massive levels (>1000 pg/mL) or the paradoxical secretin response seen here. * **B. Pernicious Anemia:** This causes hypergastrinemia due to **achlorhydria** (loss of feedback inhibition) [2][3]. However, the question specifies high acid output; in pernicious anemia, acid output is zero [3]. * **C. Renal Failure:** Gastrin is cleared by the kidneys, so levels can rise in renal failure. However, it does not cause the profound acid hypersecretion or the specific secretin test results characteristic of a gastrinoma. **NEET-PG High-Yield Pearls:** * **Most common location:** The **Gastrinoma Triangle** (confluence of cystic/common bile duct, junction of 2nd/3rd parts of duodenum, and neck/body of pancreas). * **Most common site:** Duodenum (more common than pancreas). * **Screening:** Best initial test is Fasting Serum Gastrin. * **Association:** 25% of cases occur as part of **MEN1** (3Ps: Parathyroid, Pancreas, Pituitary) [1].

Q: All of the following drugs are used in the management of hepatic encephalopathy except?

Phenobarbitone. **Explanation:** The primary goal in managing **Hepatic Encephalopathy (HE)** is to reduce the production and absorption of ammonia ($NH_3$), which is neurotoxic. **Why Phenobarbitone is the correct answer:** **Phenobarbitone** is a barbiturate that acts as a Central Nervous System (CNS) depressant. In hepatic encephalopathy, the brain is already in a state of metabolic depression due to hyperammonemia and increased GABAergic tone. Administering Phenobarbitone would **worsen the altered sensorium** and could precipitate a coma. Furthermore, it is metabolized by the liver, which is already failing in these patients. (Note: Phenobarbitone is used in Crigler-Najjar syndrome type II to induce glucuronyltransferase, but not in HE). **Why the other options are used:** * **L-ornithine L-aspartate (LOLA):** These are substrates for the urea cycle and glutamine synthesis, helping to detoxify ammonia into urea and glutamine in the liver and muscles. * **Rifaximin:** A non-absorbable antibiotic that eliminates ammonia-producing bacteria in the gut. It is currently the preferred add-on therapy to lactulose. * **Lactulose:** A non-absorbable disaccharide that acts as an osmotic laxative. It is fermented by colonic bacteria into organic acids, lowering the pH (acidifying the gut). This converts absorbable $NH_3$ into non-absorbable $NH_4^+$ (Ammonia Trapping). **NEET-PG High-Yield Pearls:** * **First-line treatment:** Lactulose (aim for 2–3 soft stools/day). * **Drug of choice for prevention of recurrence:** Rifaximin. * **Neomycin:** Another antibiotic used, but limited by side effects like ototoxicity and nephrotoxicity. * **Flumazenil:** May be used transiently if benzodiazepine-like substances are suspected of worsening the encephalopathy.

Q: A 20-year-old male presents with mucus and repeated gastrointestinal bleeding. The patient is positive for ANCA. What is the most likely diagnosis?

Ulcerative colitis. ### Explanation **Correct Option: A. Ulcerative Colitis** The clinical presentation of a young patient with mucus in stools and recurrent gastrointestinal bleeding (hematochezia) is classic for Inflammatory Bowel Disease (IBD). The presence of **p-ANCA (Perinuclear Anti-Neutrophil Cytoplasmic Antibodies)** is a highly specific serological marker for **Ulcerative Colitis (UC)**, seen in 60–70% of cases [1]. In UC, inflammation is typically limited to the mucosa and submucosa, starting in the rectum and extending proximally, leading to friable mucosa that bleeds easily [2]. **Why other options are incorrect:** * **B. Crohn’s Disease:** While it also presents with GI symptoms, it is more commonly associated with **ASCA (Anti-Saccharomyces cerevisiae antibodies)** rather than ANCA. Bleeding is less common than in UC because the inflammation is transmural and often spares the rectum [2], [3]. * **C. Radiation Colitis:** This occurs following pelvic radiotherapy (e.g., for prostate or cervical cancer). It is unlikely in a 20-year-old without a history of malignancy/radiation and has no association with ANCA. * **D. Ischemic Bowel Disease:** This typically affects elderly patients with cardiovascular risk factors (atrial fibrillation, atherosclerosis). It presents with sudden onset "pain out of proportion to physical findings," not chronic mucus and bleeding in a young adult. **High-Yield Clinical Pearls for NEET-PG:** * **Serology:** UC = p-ANCA (+); Crohn’s = ASCA (+). * **Smoking Paradox:** Smoking is **protective** in Ulcerative Colitis but a **risk factor** for Crohn’s Disease. * **Pathology:** UC shows "Crypt Abscesses" and is continuous; Crohn’s shows "Non-caseating Granulomas" and "Skip Lesions" [2], [3]. * **Complications:** Toxic megacolon and Primary Sclerosing Cholangitis (PSC) are more strongly associated with UC [1].

Q: A patient presents to a physician with "heartburn" and dysphagia. Esophageal motility studies demonstrate a near absence of smooth muscle peristalsis and lower esophageal sphincter tone. No mass lesions are noted, and the esophagus is not dilated. Which of the following findings would most likely also be present?

Thick skin. **Explanation:** The clinical presentation of heartburn and dysphagia, combined with manometric findings of **absent peristalsis** and **decreased Lower Esophageal Sphincter (LES) tone**, is classic for **Systemic Sclerosis (Scleroderma)**. [3] In Scleroderma, the esophageal smooth muscle undergoes atrophy and fibrosis. [3] This leads to an incompetent LES (causing severe GERD/heartburn) and aperistalsis (causing dysphagia). Since the LES is "wide open" rather than obstructed, the esophagus typically does not dilate significantly, unlike in Achalasia. [1] **Thick skin (Sclerodactyly)** is the hallmark cutaneous finding of this systemic disease. [2] **Analysis of Incorrect Options:** * **A & B (Anemia & Atrophic glossitis):** These are features of **Plummer-Vinson Syndrome**, which presents with esophageal webs and iron-deficiency anemia. However, it does not cause the specific manometric pattern of low LES pressure. * **C (Hourglass stomach):** This is the classic radiological description of a **Sliding Hiatal Hernia**. While hiatal hernias cause heartburn, they do not explain the global absence of esophageal peristalsis. **NEET-PG High-Yield Pearls:** * **Manometry Contrast:** * **Achalasia:** *Increased* LES pressure + Failure to relax + Aperistalsis. [1] * **Scleroderma:** *Decreased* LES pressure + Aperistalsis. [3] * **CREST Syndrome:** Remember the pentad: **C**alcinosis, **R**aynaud’s, **E**sophageal dysmotility, **S**clerodactyly, and **T**elangiectasia. [2] * **Autoantibody:** Anti-Scl-70 (diffuse) and Anti-centromere (limited/CREST).

Q: Which of the following is NOT true regarding Zollinger Ellison syndrome?

Decreased ratio of basal acid output to maximal acid output. **Explanation:** Zollinger-Ellison Syndrome (ZES) is caused by a gastrin-secreting tumor (gastrinoma), typically located in the "gastrinoma triangle." This leads to massive gastric acid hypersecretion. **1. Why Option D is the Correct Answer (The False Statement):** In ZES, the **Basal Acid Output (BAO)** is significantly elevated because the tumor continuously secretes gastrin. While the **Maximal Acid Output (MAO)** (stimulated by pentagastrin) is also high, the stomach is already secreting near its maximum capacity at baseline. Therefore, the **BAO/MAO ratio is increased** (typically >0.6 or 60%). A decreased ratio would imply low baseline acid production, which is the opposite of ZES pathophysiology. **2. Why the other options are wrong (True Statements):** * **A. Diarrhea:** This is a common symptom (seen in ~50% of patients). It occurs because the massive acid load inactivates pancreatic enzymes (lipase) and damages the intestinal mucosa, leading to malabsorption and steatorrhea. * **B. Recurrence after operation:** ZES has a high rate of recurrence, especially in patients with MEN-1 syndrome, where tumors are often small, multiple, and difficult to localize. * **C. Hypergastrinemia:** This is the hallmark of ZES. Fasting serum gastrin levels are typically >1000 pg/mL. **High-Yield Clinical Pearls for NEET-PG:** * **Diagnosis:** The best initial test is Fasting Serum Gastrin. The most sensitive/confirmatory test is the **Secretin Stimulation Test** (Secretin causes a paradoxical *increase* in gastrin in ZES). * **Location:** Most common site is the **Duodenum**, followed by the Pancreas. * **Association:** 25% of cases are associated with **MEN-1** (3Ps: Parathyroid, Pancreas, Pituitary). * **Ulcer Site:** Look for ulcers in "atypical" locations, such as the distal duodenum or jejunum.

Q: Congenital Wilson's disease is characterized by which of the following?

May present as acute hepatitis. **Explanation:** Wilson’s Disease (Hepatolenticular degeneration) is an autosomal recessive disorder caused by a mutation in the **ATP7B gene** on chromosome 13. This leads to impaired biliary copper excretion and failure to incorporate copper into ceruloplasmin, resulting in toxic copper accumulation in the liver, brain, and cornea. **Why Option B is correct:** Wilson’s disease is a "great masquerader" in hepatology. While it is a chronic condition, it frequently presents as **acute hepatitis**, which can progress to fulminant hepatic failure (often characterized by Coombs-negative hemolytic anemia and low alkaline phosphatase levels) [1]. Hepatic symptoms typically manifest in childhood or adolescence (ages 5–15), whereas neuropsychiatric symptoms appear later [1]. **Why other options are incorrect:** * **Option A:** Kayser-Fleischer (KF) rings are caused by copper deposition in the **Descemet’s membrane** of the cornea. They are **never present at birth** [1]; they develop over time as copper stores saturate the liver and spill into the systemic circulation. * **Option C:** In Wilson’s disease, there is **increased 24-hour urinary copper excretion** (>100 μg/day) because non-ceruloplasmin-bound copper is filtered by the kidneys. * **Option D:** The hallmark of the disease is **increased hepatic copper concentration** (>250 μg/g dry weight), as the liver is the primary site of accumulation. **NEET-PG High-Yield Pearls:** * **Best Initial Screening Test:** Serum Ceruloplasmin (decreased <20 mg/dL). * **Gold Standard Diagnosis:** Liver biopsy for copper quantification. * **Most Sensitive Finding for Neuro-Wilson’s:** "Face of the Giant Panda" sign on MRI Brain [1]. * **Treatment of Choice:** Chelating agents like **D-Penicillamine** (requires Pyridoxine supplementation) or Trientine. Zinc is used for maintenance or asymptomatic patients.

Question 1

A 45-year-old woman presents with jaundice, pruritus, and periocular and intradigital xanthomas. Her laboratory results indicate a significantly increased alkaline phosphatase and a positive test for antimitochondrial antibodies. What is the most likely cause of her symptoms?

Accepted Answer

Primary biliary cirrhosis

Answer

Leptospirosis

Answer

Macronodular cirrhosis

Answer

Primary sclerosing cholangitis

Question 2

Which of the following statements about Hepatitis C is true?

Accepted Answer

It is the most common indication for liver transplant.

Answer

It is a DNA virus.

Answer

It does not cause liver cancer.

Answer

It does not cause coinfection with hepatitis B.

Question 3

A patient complains of intermittent dysphagia, which is equal for both solids and liquids. What is the most common cause?

Accepted Answer

Diffuse Esophageal Spasm (DES)

Answer

Achalasia

Answer

Esophageal Stricture

Answer

Carcinoma

Question 4

A 50-year-old woman presents with duodenal ulcer disease and high basal acid secretory outputs. Secretin stimulated serum gastrin levels are in excess of 1000pg/mL. She has a long history of ulcer disease that has not responded to intense medical therapy. What is the most likely diagnosis?

Accepted Answer

Zollinger-Ellison syndrome

Answer

Hyperparathyroidism

Answer

Pernicious anemia

Answer

Renal failure

Question 5

All of the following drugs are used in the management of hepatic encephalopathy except?

Accepted Answer

Phenobarbitone

Answer

L-ornithine L-aspartate

Answer

Rifaximin

Answer

Lactulose

Question 6

What is the most common metabolic disturbance in cirrhosis?

Accepted Answer

Metabolic alkalosis

Answer

Metabolic acidosis

Answer

Respiratory acidosis

Answer

Respiratory alkalosis

Question 7

A 20-year-old male presents with mucus and repeated gastrointestinal bleeding. The patient is positive for ANCA. What is the most likely diagnosis?

Accepted Answer

Ulcerative colitis

Answer

Crohn's disease

Answer

Radiation colitis

Answer

Ischemic bowel disease

Question 8

A patient presents to a physician with "heartburn" and dysphagia. Esophageal motility studies demonstrate a near absence of smooth muscle peristalsis and lower esophageal sphincter tone. No mass lesions are noted, and the esophagus is not dilated. Which of the following findings would most likely also be present?

Accepted Answer

Thick skin

Answer

Anemia

Answer

Atrophic glossitis

Answer

Hourglass-shaped stomach on barium swallow

Question 9

Which of the following is NOT true regarding Zollinger Ellison syndrome?

Accepted Answer

Decreased ratio of basal acid output to maximal acid output

Answer

Diarrhoea

Answer

Recurrence after operation

Answer

Hypergastrinemia

Question 10

Congenital Wilson's disease is characterized by which of the following?

Accepted Answer

May present as acute hepatitis

Answer

Kayser-Fleischer rings are present at birth

Answer

Decreased urinary copper excretion

Answer

Decreased hepatic copper concentration

Gastroenterology — MCQs

Gastroenterology — MCQs

On this page

Practice by Chapter

Want unlimited practice?